Effect of polyethylene glycol additives on the polymorph and crystal habit of carbamazepine
Source abstract
Abstract
The effect of polyethylene glycol (PEG) with different molecular weights on carbamazepine (CBZ) crystallization was investigated by experiments and molecular dynamics (MD) simulations. The influence of PEG on the crystal morphology and solvent-mediated phase transition of CBZ was studied. It was found that PEG inhibited the CBZ III nucleation and CBZ II transition. The crystal morphology changes significantly from needle to rod when adding PEG with a molecular weight greater than 1500. MD simulations show that the binding energy sequence between the additive and the crystal surface is: E b(1 –1 –1) > E b(2 –2 1) > E b(2 –1 0), which explains the suppression of axial crystal growth. The results provide a possible method to stabilize the metastable crystal form of CBZ and improve crystal morphology.
Source: expertdata · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Crystallization and Solubility Studies · Surfactants and Colloidal Systems · Material Dynamics and Properties
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (34)
Show source-provided references
1. Garside · 2000
2. Effects of solvents and impurity on crystallization kinetics and crystal properties in a reactive crystallization of paracetamol10.1016/j.jcrysgro.2019.125150 ↗
3. Concentration of extended defects in CdZnTe single crystals: Effects of cooling rate after growth10.1016/j.jcrysgro.2012.06.024 ↗
4. A crystallization technique for obtaining large protein crystals with increased mechanical stability using agarose gel combined with a stirring technique10.1016/j.jcrysgro.2015.11.008 ↗
5. Influence of supersaturation on step evolution behavior of high concentration Fe3+ poisoned KDP crystal10.1016/j.jcrysgro.2020.125483 ↗
6. Crystallization of an unstable molecular compound using a tailor-made additive10.1016/S0022-0248(98)00032-3 ↗
7. Stabilization of a metastable polymorph of sulfamerazine by structurally related additives10.1016/S0022-0248(01)01784-5 ↗
8. The effect of tailor-made additives on crystal growth of methyl paraben: Experiments and modelling10.1016/j.jcrysgro.2016.12.103 ↗
9. Slowing the Growth Rate of Ibuprofen Crystals Using the Polymeric Additive Pluronic F12710.1021/cg200352u ↗
10. Effect of additives on size and shape of lithium carbonate crystals10.1016/j.jcrysgro.2016.12.001 ↗
11. Solubility of Carbamazepine (Form III) in Different Solvents from (275 to 343) K10.1021/je8002157 ↗
12. Investigation into the Cooling Crystallization and Transformations of Carbamazepine Using in Situ FBRM and PVM10.1021/op400066u ↗
13. A strategy for producing predicted polymorphs: catemeric carbamazepine form V
14. Structural Studies of the Polymorphs of Carbamazepine, its Dihydrate, and Two Solvates10.1021/op0500990 ↗
15. A predicted dimer-based polymorph of 10,11-dihydrocarbamazepine (Form IV)10.1039/B914365C ↗
16. Selective crystallisation of carbamazepine polymorphs on surfaces with differing properties10.1039/C7CE01317E ↗
17. In Situ Monitoring of Stirring Effects on Polymorphic Transformations during Cooling Crystallization of Carbamazepine10.1021/cg3005689 ↗
18. Influence of solvent polarity and supersaturation on template-induced nucleation of carbamazepine crystal polymorphs10.1016/j.jcrysgro.2016.09.058 ↗
19. Insight into the role of additives in controlling polymorphic outcome: A CO2-antisolvent crystallization process of carbamazepine10.1021/acs.cgd.7b00163 ↗
20. Controlling polymorphism of carbamazepine nanoparticles in a continuous supercritical-CO2 -assisted spray drying process10.1021/acs.cgd.9b00154 ↗
21. Dissolution and mechanical behaviors of recrystallized carbamazepine from alcohol solution in the presence of additives10.1016/j.jcrysgro.2004.10.158 ↗
22. Solubility Measurement and Thermodynamic Properties of Labetalol Hydrochloride in Different Solvents10.1021/acs.jced.1c00432 ↗
23. Measurement and Correlation of Solubility and Thermodynamic Properties of Vinpocetine in Nine Pure Solvents and (Ethanol + Water) Binary Solvent10.1021/acs.jced.8b00663 ↗
24. Correlation and Thermodynamic Analysis of Solubility of Mesotrione in Pure Solvents10.1021/acs.jced.9b01063 ↗
25. Electron Properties of Carbamazepine Drug in Form III10.1021/cg4002994 ↗
26. Crystal Growth of l-Alanine with Glycine-Based Oligopeptides: The Revelation for the Competitive Mechanism10.1021/acs.cgd.1c00162 ↗
27. A consistent and accurate ab initio parametrization of density functional dispersion correction (DFT-D) for the 94 elements H-Pu10.1063/1.3382344 ↗
28. A comparison of binding energy and metastable zone width for adipic acid with various additives10.1016/0022-0248(95)00300-2 ↗
29. Molecular dynamics study of polyether polyamino methylene phosphonates as an inhibitor of anhydrite crystal10.1016/j.desal.2013.05.013 ↗
30. Solubility of carbamazepine, nicotinamide and carbamazepine–nicotinamide cocrystal in ethanol–water mixtures10.1016/j.fluid.2013.11.024 ↗
31. Polymorph screening: Influence of solvents on the rate of solvent-mediated polymorphic transformation10.1002/jps.1137 ↗
32. Effect of Structurally Similar Additives on Crystal Habit of Organic Molecular Crystals at Low Supersaturation10.1021/cg3010618 ↗
33. Impact of Polymer Enrichment at the Crystal-Liquid Interface on Crystallization Kinetics of Amorphous Solid Dispersions10.1021/acs.molpharmaceut.8b01331 ↗
34. Melt Crystallization of Indomethacin Polymorphs in the Presence of Poly(ethylene oxide): Selective Enrichment of the Polymer at the Crystal-Liquid Interface10.1021/acs.molpharmaceut.0c00220 ↗